Table 2.
List of human cancer cell lines that have shown the synergistic anticancer effects with the combination
| Human cancer tissues | Human cancer cell lines used in experiment |
|---|---|
| Head, neck and lung | A549, ChaGo K-1, H292, H358, H460, H2122, NCI-H460, PC-9, SQCCY1, Tu177, Tu212, YCU-N861, YCU-H891, 38, 886LN |
| Breast | MDA-MB-231, HS578T, MCF-7 |
| Prostate | ALVA-41, CWR22Rv1, IBC-10a, LNCaP, PC-3, PC-3 AP-1, PC-3ML, PCa-20a, cancer stem cells of PC-3, RPMI8226 MM |
| Liver | BEL-7404/DOX, Hep3B |
| Colon | HCT-116, HT-29, RKO |
| Ovaries | A2780, A2780 (cisR), SKOV-ip1 (paclitaxel-sensitive), SKOVTR-ip2 (paclitaxel-resistant) |
| Malignant neuroblastoma | SH-SY5Y, SK-N-BE2 |
| Leukemia | B-cell chronic leukemia, HL-60, Jurkat T leukemia, K-562, myelogenous leukemia |
| Pancreas | Colo357, PANC-1, MIA PaCa-2 |
| Cervix | HeLa, TMCC-1 |
| Melanoma | A-375, G-361, Hs-294T |
| Skin | A431, SCC-13 |
| Stomach | BGC-823 |